[The effect of an angiotensin antagonist on blood pressure, renin and aldosterone secretion and its pathogenetic importance].
D000450:Aldosterone / Q000097:blood / Q000378:metabolism*; D000804:Angiotensin II / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors*; D001024:Aortic Valve Stenosis / Q000188:drug therapy; D001477:Bartter Syndrome / Q000150:complications; D001667:Binding, Competitive; D001794:Blood Pressure / Q000187:drug effects*; D003276:Contraceptives, Oral / Q000009:adverse effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology; D006977:Hypertension, Renal / Q000188:drug therapy; D012083:Renin / Q000097:blood / Q000378:metabolism*; D012504:Saralasin / Q000627:therapeutic use
D003276:Contraceptives, Oral; D000804:Angiotensin II; D000450:Aldosterone; D012083:Renin; D012504:Saralasin
Untersuchungen über die Wirkung eines Angiotensin-Antagonisten auf Blutdruck, Renin- und Aldosteronsekretion und deren patho- genetische Bedeutung.